戻る
「早戻しボタン」を押すと検索画面に戻ります。 [閉じる]

コーパス検索結果 (１語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します
1 atly enhanced CD44-mediated cell adhesion to hyaluronate.
2 orway rats by subretinal injection of sodium hyaluronate.
3  mice by subretinal injection of 1.4% sodium hyaluronate.
4 proximately half of the versican is bound to hyaluronate.
5 orm is independent of its ability to bind to hyaluronate.
6  oxygenated warm acellular buffer containing hyaluronate.
7 r the extracellular matrix glycosaminoglycan hyaluronate.
8 onstruct encoded a protein unable to bind to hyaluronate.
9 id not affect CD44-mediated cell adhesion to hyaluronate.
10 gnificantly modulates its ability to bind to hyaluronate.
11 ion proteins also enhanced their adhesion to hyaluronate.
12 tion between CD44 and a carbohydrate ligand, hyaluronate.
13           Injection of suprachoroidal sodium hyaluronate, 1%, in the region of the suspected break, u
14            In order to study cell binding to hyaluronate, a novel assay was developed with hyaluronat
15 ratan sulfate modification of CD44 modulates hyaluronate adhesion through its B loop domain.
16  the US Food and Drug Administration: sodium hyaluronate and poly(vinylpyrrolidone).
17 cells roll under physiologic shear forces on hyaluronate and require VCAM-1, but not ICAM-1, as ligan
18 ild-type standard CD44 isoform increased the hyaluronate binding of prostate cancer cells and suppres
19 r level of standard CD44 isoform expression, hyaluronate binding, tumorigenicity, and metastatic abil
20 te cancer cells critically requires enhanced hyaluronate binding.
21 osaminoglycan side chain attachment, impairs hyaluronate binding.
22 ibited by an anti-CD44 antibody that blocked hyaluronate binding.
23 e recognition domain of CD44 is critical for hyaluronate binding.
24 utant CD44 standard isoform did not increase hyaluronate binding; however, it equally suppressed the
25                    Use of plates coated with hyaluronate by this new method provides an ideal in vitr
26                                  Adhesion to hyaluronate by tumor cells has been shown to correlate w
27 ly lead to phagocytic ingestion and that the hyaluronate capsule and M proteins are variably importan
28  of M protein-fibrinogen interaction and the hyaluronate capsule in preventing phagocytic ingestion a
29                                       Sodium hyaluronate-carboxymethylcellulose (HA/CMC) formulations
30 stration-approved antiadhesion agent, sodium hyaluronate/carboxymethylcellulose (Seprafilm) by intrap
31                          Seprafilm, a sodium hyaluronate/carboxymethylcellulose absorbable barrier de
32             Dispersion of ABM/P-15 in sodium hyaluronate carrier (PPutty) improves the handling prope
33 te demineralized bone matrices in a 2% or 4% hyaluronate carrier, respectively.
34 6 ml/g/min), increased resistance, decreased hyaluronate clearance (17 vs. 35 microg/g liver) and low
35        Bile output, alanine transferase, and hyaluronate clearance were measured during reperfusion.
36 reservation, flow (2.0 vs. 2.0), resistance, hyaluronate clearance, and bile output were similar in b
37  in the loss of attachment of these cells to hyaluronate-coated substrate.
38 es CD44-mediated melanoma cell attachment to hyaluronate-coated surfaces, suggesting that all five si
39 n side chains contribute to the hydration of hyaluronate-containing extracellular matrices.
40 NPs can be successfully formulated in sodium hyaluronate-containing eye-drops without impairing effic
41 yaluronate, a novel assay was developed with hyaluronate covalently tethered to polystyrene plates in
42 s of the matrix components and regulation of hyaluronate density and swelling are unknown.
43 ove chondroitin sulfate, heparan sulfate, or hyaluronate did not affect CD44-mediated cell adhesion t
44 annuronate-bound states as well as the tetra-hyaluronate-docked structure.
45 ix; i.e. similar to that observed for sodium hyaluronate fibers by X-ray diffraction, but with the ac
46 vation of T cells increases their binding to hyaluronate (HA) and enables CD44-mediated primary adhes
47 ver, the levels of synovium-derived markers, hyaluronate (HA) and N-propeptide of type III procollage
48  be specifically achieved using both soluble hyaluronate (HA) and treatment of the adherent cells wit
49 riety of natural and synthetic biomaterials, hyaluronate (HA) has been considered a promising biomole
50 s been characterized in depth, regulation of hyaluronate (HA) on endothelial cells has not been exten
51 een "activated" to bind its principal ligand hyaluronate (HA) on endothelium can mediate the primary
52               Synovial fluid is a semidilute hyaluronate (HA) polymer solution, the rheology of which
53 s interactions between T lymphocyte CD44 and hyaluronate (HA), a heteropolysaccharide that is express
54 inistration of the principal ligand of CD44, hyaluronate (HA), in soluble form, can inhibit CD44-HA i
55  with four biologically relevant polyanions: hyaluronate (HA), poly-L-aspartate (PLD), poly-L-glutama
56 etention at the cell surface is dependent on hyaluronate (HA).
57 ly-vinyl-pyrrolidone for MN-ART and a sodium hyaluronate hydrogel for MN-LUM.
58 as induced by subretinal injection of sodium hyaluronate in adult wild-type (WT) and GFAP-/-Vim-/- mi
59  anesthetized cats by injecting 0.25% sodium hyaluronate in balanced salt solution into the subretina
60 k pain-relieving effect, and intra-articular hyaluronate injections may also have a limited role.
61 lation and Ser-Gly motifs in regulating CD44-hyaluronate interaction.
62               CD44-mediated cell adhesion to hyaluronate is controlled by mechanisms which are poorly
63                         Low molecular weight hyaluronate (LMW-HA) blocks interactions between T lymph
64  by the bacterial gene encoded extracellular hyaluronate lyase (HL), which degrades hyaluronan (HA),
65                                          The hyaluronate lyase (Hyl) presented on the surface of S. p
66                     As pneumococci express a hyaluronate lyase (Hyl) that cleaves hyaluronic acid int
67                     Streptococcus pneumoniae hyaluronate lyase (spnHL) is a pathogenic bacterial spre
68                     Streptococcus agalactiae hyaluronate lyase degrades primarily hyaluronan, the mai
69                                              Hyaluronate lyase enzymes degrade hyaluronan, the main p
70 rystal structure of Streptococcus pneumoniae hyaluronate lyase in the presence of HA disaccharide pro
71                     Streptococcus pneumoniae hyaluronate lyase is a surface antigen of this Gram-posi
72                     Streptococcus pneumoniae hyaluronate lyase is a surface enzyme of this Gram-posit
73                     Streptococcus agalactiae hyaluronate lyase is a virulence factor that helps this
74 yase, an enzyme which depolymerizes HA, thus hyaluronate lyase might contribute directly to bacterial
75 glycerol lipases PPA2105 and PPA1796 and the hyaluronate lyase PPA380 compared to that in untreated b
76 action between the Streptococcus peneumoniae hyaluronate lyase protein and the product, and supports
77 ased on the native Streptococcus peneumoniae hyaluronate lyase structure.
78 de hyaluronan complex with the S. agalactiae hyaluronate lyase was determined at 2.2 A resolution; th
79 ystal structures of Streptococcus pneumoniae hyaluronate lyase with tetra- and hexasaccharide hyaluro
80   Pneumococci and other streptococci produce hyaluronate lyase, an enzyme which depolymerizes HA, thu
81 bsequently observed in copper amine oxidase, hyaluronate lyase, chondroitinase, and maltose phosphory
82 onan degradation by Streptococcus pneumoniae hyaluronate lyase.
83  design of a stronger inhibitor of bacterial hyaluronate lyase.
84 ly to have an inhibitory effect on bacterial hyaluronate lyase.
85 llographic evidence for the binding of HA to hyaluronate lyase.
86            Evolutionary studies suggest that hyaluronate lyases evolved from chondroitin lyases and s
87 s of the S. agalactiae and the S. pneumoniae hyaluronate lyases.
88 se activity; however, all III-2 strains lack hyaluronate lysase activity, because the gene that encod
89 s, all RDP III-3 and III-1 strains expressed hyaluronate lysase activity; however, all III-2 strains
90 sase activity, because the gene that encodes hyaluronate lysase, hylB, is inactivated by IS1548.
91                 Versican-tuned properties of hyaluronate matrices may be a broadly used mechanism in
92 after CD44 ligation by either osteopontin or hyaluronate may account for the independent effects of C
93 cific and cannot be duplicated by the use of hyaluronate or bovine serum albumin solutions.
94 ethyl cellulose, sodium alginate, and sodium hyaluronate polymers at variable concentrations were pre
95                                      Charged hyaluronate polymers osmotically swell with water and ge
96                                      Charged hyaluronate polymers play a key role in canal morphogene
97           Moreover, CD44H on KM12L4 bound to hyaluronate poorly compared to CD44H on KM12C6.
98                                              Hyaluronate pressure shaped by anisotropic tissue stiffn
99  performed with lymphatic vessel endothelial hyaluronate receptor 1 (LYVE-1) and podoplanin antibodie
100 ning showed significant up-regulation of the hyaluronate receptor CD44 and stem cell factor receptor
101 icles bound to and inhibited DCs through the hyaluronate receptor CD44.
102 rkers LYVE-1 (lymphatic vascular endothelium hyaluronate receptor) and podoplanin contribute to lymph
103 st c-Kit, CD34 (binds L-selectin), and CD44 (hyaluronate receptor) receptors for biotinylated SCF res
104                          CD44, a polymorphic hyaluronate receptor, may participate in chronic inflamm
105 tial N-linked glycosylation sites within the hyaluronate recognition domain of CD44 is critical for h
106  indicate that CD44 and its principal ligand hyaluronate represent another receptor/carbohydrate liga
107                                              Hyaluronate rhodamine (5000 Da) was successfully deliver
108 try of blood into the cochlea and the use of hyaluronate seem to be reasonably supported, whereas the
109 o evaluate outcomes from the use of a sodium hyaluronate (SH)-based comfort drop, instilled before th
110 dium alginate, sodium guluronate, and sodium hyaluronate) similarly increased cell iron uptake.
111 which is a 3D printed gelatin/elastin/sodium-hyaluronate soft thick porous membrane with large pores
112  or an increase in CD44-mediated adhesion to hyaluronate, suggesting that complex N-linked oligosacch
113 tive at photolabeling Streptococcus pyogenes hyaluronate synthase in membrane preparations.
114 s inserted into the hasA gene, which encodes hyaluronate synthase, we found that all bacteria recover
115 ther 20 mg/ml of IL-1ra mixed in 0.2% sodium hyaluronate vehicle (n=28) or placebo alone (n=25).
116               Subretinal injection of sodium hyaluronate was performed in eight-week-old C57BL/6J mic
117          CD44, the cell surface receptor for hyaluronate, was overexpressed in COX-2-S cells, and spe

 
Page Top